Christos Tzimas1, John Terrovitis2, Stephan E Lehnart3, Evangelia G Kranias4, Despina Sanoudou5. 1. Molecular Biology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece. 2. 3rd Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece. 3. Clinic of Cardiology & Pulmonology, University Medical Center Goettingen, Goettingen, Germany. 4. Molecular Biology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Department of Pharmacology and Cell Biophysics, College of Medicine, University of Cincinnati, Cincinnati, Ohio. 5. Molecular Biology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: dsanoudou@med.uoa.gr.
Abstract
BACKGROUND: Aberrant calcium signaling is considered one of the key mechanisms contributing to arrhythmias, especially in the context of heart failure. In human heart failure, there is significant down-regulation of the sarcoplasmic reticulum (SR) protein junctin, and junctin deficiency in mice is associated with stress-induced arrhythmias. OBJECTIVE: The purpose of this study was to determine whether the increased SR Ca(2+) leak and arrhythmias associated with junctin ablation may be associated with increased calcium/calmodulin-dependent protein kinase II (CaMKII) activity and phosphorylation of the cardiac ryanodine receptor (RyR2) and whether pharmacologic inhibition of CaMKII activity may prevent these arrhythmias. METHODS: Using a combination of biochemical, cellular, and in vivo approaches, we tested the ability of KN-93 to reverse aberrant CaMKII phosphorylation of RyR2. Specifically, we performed protein phosphorylation analysis, in vitro cardiomyocyte contractility and Ca(2+) kinetics, and in vivo ECG analysis in junctin-deficient mice. RESULTS: In the absence of junctin, RyR2 channels displayed CaMKII-dependent hyperphosphorylation. Notably, CaMKII inhibition by KN-93 reduced the in vivo incidence of stress-induced ventricular tachycardia by 65% in junctin null mice. At the cardiomyocyte level, KN-93 reduced the percentage of junctin null cells exhibiting spontaneous Ca(2+) aftertransients and aftercontractions under stress conditions by 35% and 37%, respectively. At the molecular level, KN-93 blunted the CaMKII-mediated hyperphosphorylation of RyR2 and phospholamban under stress conditions. CONCLUSION: Our data suggest that CaMKII inhibition is effective in preventing arrhythmogenesis in the setting of junctin ablation through modulation of both SR Ca(2+) release and uptake. Thus, it merits further investigation as promising molecular therapy.
BACKGROUND: Aberrant calcium signaling is considered one of the key mechanisms contributing to arrhythmias, especially in the context of heart failure. In humanheart failure, there is significant down-regulation of the sarcoplasmic reticulum (SR) protein junctin, and junctin deficiency in mice is associated with stress-induced arrhythmias. OBJECTIVE: The purpose of this study was to determine whether the increased SR Ca(2+) leak and arrhythmias associated with junctin ablation may be associated with increased calcium/calmodulin-dependent protein kinase II (CaMKII) activity and phosphorylation of the cardiac ryanodine receptor (RyR2) and whether pharmacologic inhibition of CaMKII activity may prevent these arrhythmias. METHODS: Using a combination of biochemical, cellular, and in vivo approaches, we tested the ability of KN-93 to reverse aberrant CaMKII phosphorylation of RyR2. Specifically, we performed protein phosphorylation analysis, in vitro cardiomyocyte contractility and Ca(2+) kinetics, and in vivo ECG analysis in junctin-deficient mice. RESULTS: In the absence of junctin, RyR2 channels displayed CaMKII-dependent hyperphosphorylation. Notably, CaMKII inhibition by KN-93 reduced the in vivo incidence of stress-induced ventricular tachycardia by 65% in junctin null mice. At the cardiomyocyte level, KN-93 reduced the percentage of junctin null cells exhibiting spontaneous Ca(2+) aftertransients and aftercontractions under stress conditions by 35% and 37%, respectively. At the molecular level, KN-93 blunted the CaMKII-mediated hyperphosphorylation of RyR2 and phospholamban under stress conditions. CONCLUSION: Our data suggest that CaMKII inhibition is effective in preventing arrhythmogenesis in the setting of junctin ablation through modulation of both SR Ca(2+) release and uptake. Thus, it merits further investigation as promising molecular therapy.
Authors: S O Marx; S Reiken; Y Hisamatsu; M Gaburjakova; J Gaburjakova; Y M Yang; N Rosemblit; A R Marks Journal: J Cell Biol Date: 2001-05-14 Impact factor: 10.539
Authors: M Sumi; K Kiuchi; T Ishikawa; A Ishii; M Hagiwara; T Nagatsu; H Hidaka Journal: Biochem Biophys Res Commun Date: 1991-12-31 Impact factor: 3.575
Authors: Lucia Brunello; Jessica L Slabaugh; Przemyslaw B Radwanski; Hsiang-Ting Ho; Andriy E Belevych; Qing Lou; Haiyan Chen; Carlo Napolitano; Francesco Lodola; Silvia G Priori; Vadim V Fedorov; Pompeo Volpe; Michael Fill; Paul M L Janssen; Sándor Györke Journal: Proc Natl Acad Sci U S A Date: 2013-06-03 Impact factor: 11.205